期刊文献+

不同类型冠状动脉支架置入与宿主的生物相容性反应 被引量:10

Biocompatibility of different types of coronary artery stent with the host after implantation
暂未订购
导出
摘要 经皮冠状动脉支架置入后,对血管壁刺激以及置入过程中造成血管内膜损伤、冠状动脉斑块破裂,导致血小板和炎症细胞聚集、浸润,释放各种生长因子,促进血管收缩和平滑肌细胞由中膜迁移到内膜并增殖,促进内膜增厚,形成血栓而致支架内再狭窄的发生。药物洗脱支架能给局部组织提供足够的治疗药物浓度,又避免了由于血药浓度过高而引起的全身毒副作用,有抗血管重塑和抗增殖作用,使血管再狭窄率降低到10%。药物涂层支架和药物洗脱支架降低了支架置入后血管内再狭窄率,生物可降解支架已成为目前研究关注的焦点和热点。 Following percutaneous coronary artery implantation, stimulation to vascular wall, vascular intimal injury and plaque disruption of the coronary artery can induce aggregation and infiltration of blood plaque and inflammatory cells, which release various growth factors, improve vasoconstriction, and promote immigration from media area to intimal area and proliferation of smooth muscle cells, accelerate intimal thickening, resulting in thrombus and restenosis in stent. Drug-eluting stent provides enough drug concentration for local tissues, avoids general side effects induced by high plasma concentrations of drugs, has effects against vessel remodeling and proliferation, and reduces restenosis rate of vessels by 10%. Drug eluting stent and drug-eluting stent decrease vascular restenosis rate after stent implantation. Biodegradable stent has been a key hot point in present research.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2008年第35期6931-6934,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献28

  • 1Sigwart U, Puel J, Mirkovitch V, et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987;316(12):701-706
  • 2Serruys PW, de Jaegere P, Kiemeneij F, et al, A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994;331(8):489-495
  • 3Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators, N Engl J Med 1994;331(8):496-501
  • 4毕亚艳,田野,谷宏越,傅世英.放射性NiTi合金血管内支架可行性及安全性的实验观察[J].哈尔滨医科大学学报,2003,37(3):211-214. 被引量:4
  • 5Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346(23): 1773-1780
  • 6Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349(14): 1315-1323
  • 7Schofer J, Schltiter M, Gershlick AH, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: d6uble-blind, randomised controlled trial (E-SIRIUS). Lancet 2003 ;362(9390): 1093 - 1099
  • 8Schampaert E, Cohen EA, Schlfiter M, et al, The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 2004;43(6): 1110-1115
  • 9Grube E, Silber S, Hauptmann KE, et al. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 2003;107(1):38-42
  • 10Colombo A, Drzewiecki J, Banning A, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003;108(7):788-794

二级参考文献1

  • 1陈星.血管介入放射治疗[M].北京医科大学中国协和医科大学联合出版社,1998.61.

共引文献3

同被引文献100

引证文献10

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部